| Dr Natalie Maida, DO | |
|
532 W Pittsburgh St, Excela Health- Westmoreland Hospital, Greensburg, PA 15601-2239 | |
| (724) 832-4000 | |
| Not Available |
| Full Name | Dr Natalie Maida |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 532 W Pittsburgh St, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780827790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OS016459 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Maine Medical Center | 2567379563 | 347 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
| Entity Name | Bridgton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154370153 PECOS PAC ID: 8123919099 Enrollment ID: O20040322000534 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of Lewiston-auburn, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225074362 PECOS PAC ID: 7911898796 Enrollment ID: O20040322001303 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
| Entity Name | Rumford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205991122 PECOS PAC ID: 3870583511 Enrollment ID: O20040514000890 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natalie Maida, DO 173 Marguerite Rd, Latrobe, PA 15650-5159 Ph: (412) 849-2563 | Dr Natalie Maida, DO 532 W Pittsburgh St, Excela Health- Westmoreland Hospital, Greensburg, PA 15601-2239 Ph: (724) 832-4000 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
› Verified 6 days ago
Ritesh Senapati, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-689-1819 | |
Jessica Erin O'connor, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 532 W Pittsburgh St, Excela Health Department Of Anesthesia, Greensburg, PA 15601 Phone: 724-832-4003 | |
Dr. Randolph B Wood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-832-4003 | |
Dr. Benjamin Michael Kristobak, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-832-4000 | |
Dr. Charles A Defrancesco, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Brush Run Rd, Greensburg, PA 15601 Phone: 724-691-0354 | |
David William Beyer, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 348 Donohoe Rd, Greensburg, PA 15601 Phone: 724-552-0068 | |
Dr. Kristi Dana Langston, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-832-4000 |